Better health. Within reach. Every day. News Hikma continues strong 2021 performance and reiterates full year guidance News Hikma and Almirall enter an exclusive licensing agreement to market Finjuve in the Middle East and North Africa region Recent event Watch the replay of our Generics Meet the Management event. 2021 Interim Results Watch our CEO Siggi Olafsson summarise our 2021 half year performance #OwnYour Career @Hikma Meet Janaina, Maintenance Planner, Engineering at Hikma Portugal. She loves tackling new challenges every day and using her communications and problem solving skills on the job. Case study Our support and impact; improving patient’s access to ritonavir Insight Kept out of reach - tackling the enduring challenge of access to medicine Update Hikma update regarding COVID-19 Find out more Who we are. We make high quality medicines and make them accessible to the people that need them. News Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™ in MENA Find out more Our commitment to sustainability Find out more Our Modern Slavery Act statement. Hikma Home Back to top Useful links About Products Investors News Careers Contact Worldwide Leadership Stay in touch Subscribe to our newsletter Follow us instagram Created with Sketch. © Hikma Pharmaceuticals PLC 2021 Terms of use Cookie policy Disclaimer Privacy policy Community guidelines Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.